Copyright
©The Author(s) 2025.
World J Gastroenterol. Aug 28, 2025; 31(32): 109383
Published online Aug 28, 2025. doi: 10.3748/wjg.v31.i32.109383
Published online Aug 28, 2025. doi: 10.3748/wjg.v31.i32.109383
Figure 1 Patient enrollment and sample collection.
R: Resectable; BR: Borderline resectable; PDAC: Pancreatic ductal adenocarcinoma; NAT: Neoadjuvant therapy; pCR: Pathologiccaly complete response; pTis: Pathological carcinoma in situ.
- Citation: Murakami T, Imamura M, Kimura Y, Watanabe K, Shinohara Y, Nakamura T, Low SK, Motoya M, Kawakami Y, Masaki Y, Kubo T, Yoshida M, Yoshida E, Kato T, Kukita K, Kyuno D, Takemasa I. Role of preoperative circulating tumor DNA in predicting occult metastases in resectable and borderline resectable pancreatic ductal adenocarcinoma. World J Gastroenterol 2025; 31(32): 109383
- URL: https://www.wjgnet.com/1007-9327/full/v31/i32/109383.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i32.109383